These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 21177832

  • 1. Reversal of endogenous dopamine receptor silencing in pituitary cells augments receptor-mediated apoptosis.
    Al-Azzawi H, Yacqub-Usman K, Richardson A, Hofland LJ, Clayton RN, Farrell WE.
    Endocrinology; 2011 Feb; 152(2):364-73. PubMed ID: 21177832
    [Abstract] [Full Text] [Related]

  • 2. Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs.
    Peverelli E, Mantovani G, Vitali E, Elli FM, Olgiati L, Ferrero S, Laws ER, Della Mina P, Villa A, Beck-Peccoz P, Spada A, Lania AG.
    J Clin Endocrinol Metab; 2012 Mar; 97(3):967-77. PubMed ID: 22259062
    [Abstract] [Full Text] [Related]

  • 3. Epigenomic silencing of the BMP-4 gene in pituitary adenomas: a potential target for epidrug-induced re-expression.
    Yacqub-Usman K, Duong CV, Clayton RN, Farrell WE.
    Endocrinology; 2012 Aug; 153(8):3603-12. PubMed ID: 22700770
    [Abstract] [Full Text] [Related]

  • 4. The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas.
    Wang S, Wang A, Zhang Y, Zhu K, Wang X, Chen Y, Wu J.
    BMC Endocr Disord; 2021 Nov 23; 21(1):235. PubMed ID: 34814904
    [Abstract] [Full Text] [Related]

  • 5. Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine.
    Li Q, Su Z, Liu J, Cai L, Lu J, Lin S, Xiong Z, Li W, Zheng W, Wu J, Zhuge Q, Wu Z.
    Mol Cell Endocrinol; 2014 Jan 25; 382(1):377-384. PubMed ID: 24184771
    [Abstract] [Full Text] [Related]

  • 6. Regulation of growth hormone and prolactin gene expression and secretion by chimeric somatostatin-dopamine molecules.
    Gruszka A, Ren SG, Dong J, Culler MD, Melmed S.
    Endocrinology; 2007 Dec 25; 148(12):6107-14. PubMed ID: 17656461
    [Abstract] [Full Text] [Related]

  • 7. Bromocriptine and dopamine mediate independent and synergistic apoptotic pathways in pituitary cells.
    Rowther FB, Richardson A, Clayton RN, Farrell WE.
    Neuroendocrinology; 2010 Dec 25; 91(3):256-67. PubMed ID: 20110659
    [Abstract] [Full Text] [Related]

  • 8. Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas.
    Cai L, Leng ZG, Guo YH, Lin SJ, Wu ZR, Su ZP, Lu JL, Wei LF, Zhuge QC, Jin K, Wu ZB.
    Endocrine; 2016 Jun 25; 52(3):641-51. PubMed ID: 26662185
    [Abstract] [Full Text] [Related]

  • 9. Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes.
    Yacqub-Usman K, Duong CV, Clayton RN, Farrell WE.
    Endocrinology; 2013 May 25; 154(5):1711-21. PubMed ID: 23539512
    [Abstract] [Full Text] [Related]

  • 10. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
    Cristina C, Díaz-Torga GS, Goya RG, Kakar SS, Perez-Millán MI, Passos VQ, Giannella-Neto D, Bronstein MD, Becu-Villalobos D.
    Mol Cancer; 2007 Jan 12; 6():4. PubMed ID: 17222350
    [Abstract] [Full Text] [Related]

  • 11. Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.
    Miller M, Chen S, Woodliff J, Kansra S.
    Endocrinology; 2008 Aug 12; 149(8):4158-67. PubMed ID: 18450960
    [Abstract] [Full Text] [Related]

  • 12. Fetal Alcohol Exposure Reduces Dopamine Receptor D2 and Increases Pituitary Weight and Prolactin Production via Epigenetic Mechanisms.
    Gangisetty O, Wynne O, Jabbar S, Nasello C, Sarkar DK.
    PLoS One; 2015 Aug 12; 10(10):e0140699. PubMed ID: 26509893
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of nerve growth factor on expression of dopamine 2 receptor subtypes in GH3 rat pituitary tumor cells.
    Su Z, Jiang X, Wang C, Liu J, Chen Y, Li Q, Wu J, Zheng W, Zhuge Q, Jin K, Wu Z.
    Endocrine; 2012 Dec 12; 42(3):670-5. PubMed ID: 22684586
    [Abstract] [Full Text] [Related]

  • 14. Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas.
    Renner U, Arzberger T, Pagotto U, Leimgruber S, Uhl E, Müller A, Lange M, Weindl A, Stalla GK.
    J Clin Endocrinol Metab; 1998 Apr 12; 83(4):1368-75. PubMed ID: 9543168
    [Abstract] [Full Text] [Related]

  • 15. Absence of high affinity dopamine receptor in GH3 cells: a prolactin-secreting clone resistant to the inhibitory action of dopamine.
    Cronin MJ, Faure N, Martial JA, Weiner RI.
    Endocrinology; 1980 Mar 12; 106(3):718-23. PubMed ID: 7353539
    [Abstract] [Full Text] [Related]

  • 16. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
    Kitchen MO, Yacqub-Usman K, Emes RD, Richardson A, Clayton RN, Farrell WE.
    Pituitary; 2015 Oct 12; 18(5):674-84. PubMed ID: 25557289
    [Abstract] [Full Text] [Related]

  • 17. D2 dopamine receptor-mediated antiproliferation in a small cell lung cancer cell line, NCI-H69.
    Senogles SE.
    Anticancer Drugs; 2007 Aug 12; 18(7):801-7. PubMed ID: 17581302
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells.
    Huang J, Zhang F, Jiang L, Hu G, Sun W, Zhang C, Ding X.
    Cancer Res Treat; 2017 Apr 12; 49(2):358-373. PubMed ID: 27488872
    [Abstract] [Full Text] [Related]

  • 19. Leukemia inhibitory factor regulates prolactin secretion in prolactinoma and lactotroph cells.
    Ben-Shlomo A, Miklovsky I, Ren SG, Yong WH, Heaney AP, Culler MD, Melmed S.
    J Clin Endocrinol Metab; 2003 Feb 12; 88(2):858-63. PubMed ID: 12574225
    [Abstract] [Full Text] [Related]

  • 20. Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice.
    Cristina C, Díaz-Torga G, Baldi A, Góngora A, Rubinstein M, Low MJ, Becú-Villalobos D.
    Endocrinology; 2005 Jul 12; 146(7):2952-62. PubMed ID: 15817666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.